期刊文献+

脂肪细胞特异性核酸适体对肥胖小鼠脂肪代谢的影响 被引量:1

Adipocyte specific aptamer impact on lipometabolism in obesity mouse
下载PDF
导出
摘要 目的通过研究体外筛选的脂肪细胞特异性核酸适体adipo 8在肥胖小鼠体内是否可以与脂肪组织特异性结合,初步探讨adipo 8在肥胖小鼠体内对脂肪组织成脂的影响作用。方法 1高脂喂养雄性C57BL/6小鼠60只复制肥胖小鼠模型;2取小鼠4只,腹腔注射cy 3荧光标记并硫代碱基修饰,结合聚乙二醇的adipo 8,注射后1 h取肝脏、肾脏、肌肉及附睾脂肪组织于冷冻切片机制成冰冻切片2块,荧光显微镜下观察各组织荧光信号和HE染色;3取小鼠24只分为未修饰adipo 8组和修饰adipo 8组,每组12只。Cy 3荧光标记的未修饰和修饰adipo 8分别腹腔注射入两组小鼠体内,注射后30 min、1 h、2 h、4 h、8 h、24 h分别取附睾脂肪组织制成冷冻切片,荧光显微镜下显像;432只小鼠分为随机序列组和adipo 8组,每组16只。微型渗透压泵埋入小鼠腹腔,分别连续腹腔输注随机序列和修饰adipo 8,于连续腹腔输注第1、2、3、4周,分别取附睾脂肪组织制成冷冻切片,HE染色观察分析脂肪细胞大小改变。结果 1腹腔注射cy 3荧光标记并修饰的adipo 8,1 h荧光显微镜下观察显示:脂肪组织可见非常强的荧光信号,而其余组织仅可见微弱信号;2未修饰adipo 8与脂肪组织结合弱且作用时间短,修饰adipo 8与脂肪组织结合强且时间长。修饰adipo 8组中,脂肪组织的荧光信号呈先增后减,1 h最强,30 min和24 h信号弱;3光学显微镜相同放大倍数单个视野内,第1周,adipo 8组脂肪细胞大小较随机序列组无明显差异(P>0.05),第2、3、4周,adipo 8组脂肪细胞小于随机序列组(P<0.05)。结论 1核酸适体adipo 8在肥胖小鼠体内可与白色脂肪组织高度特异性结合;2Adipo 8经硫代碱基修饰、结合聚乙二醇,增强了其与脂肪组织结合的强度及延长结合时间;3Adipo 8在肥胖小鼠体内可以抑制脂肪组织成脂,并且该作用随着时间的延长而加强,即adipo 8在体内抑制成脂的作用呈时间依赖性。 [Objective] To investigate in vitro screening the adipocyte specific aptamer adipo 8 can com- bine with adipose tissue specifically in obesity mouse and adipo 8 impact on adipogenic in obesity mouse preliminarily. [Methods] 60 Obesity mouse model were established through feeding high fat diet to male C57BL/6 mouse. 4 mouse received intraperitoneal injection phosphorothioate modified and with polyethylene glycol adipo 8 fluorescein labeled by cy 3. Taking the liver, kidney, muscle and epididymal adipose tissue made into two frozen sections using freezing microtome after injection of 1 h, observed the tissue fluorescence signal using the fluorescence microscope and HE staining. 24 mouse divided into unmodified adipo 8 and modified adipo 8 groups, each of 12. They received intraperitoneal injection unmodified or modified adipo 8 fluorescein labeled by cy 3 separately. Taking the epididymal adipose tissue made into frozen section and im- aged using the upright fluorescence microscope after injection of 30 min, 1 h, 2 h, 4 h, 8 h, 24 h. 32 mouse divided into random sequence and adipo 8 groups, each of 16. The mini-osmotic pumps embedded into mouse peritoneal. Two groups accepted continuous intraperitoneal infusion random sequence or modified adipo 8 respectively. Taking epididymal adipose tissue made into frozen section, observed adipocyte size using HE staining 1, 2, 3, 4 week later respectively. [Results] Intraperitoneal injection modified adipo 8 fluorescein la- beled by cy 3 for 1 h, the result showed it was very strong fluorescence signal in adipose tissue while the other was only weak signals under the upright fluorescence microscope. Unmodified adipo 8 combined with adipose tissue weak and short time and modified adipo 8 was strong and long. In group of modified adipo 8, the fluorescence signal of adipose tissue first increased and then decreased. It was the strongest at 1 h and only weak signal at 30 min and 24 h. It showed that the adipocyte size was no significant difference between adipo 8 group and random sequence group in the first week (P 〉0.05) and it was smaller than random se- quence group from the second to the forth week (P〈0.05) by using optical microscope with the same magnifi- cation single vision observation. [Conclusions] Adipo 8 can combine with white adipose tissue specifically in obesity mouse. Adipo 8 by phosphorothioate modified and with polyethylene glycol, enhances its binding with adipose tissue strength and extends the time. Adipo 8 can inhibit adipogenic in obesity mouse and the effect is strengthen with the extension of time, namely the effect of adipo 8 inhibition of adipogenic is time depen- dent in vivo.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2014年第26期12-17,共6页 China Journal of Modern Medicine
基金 国家自然科学基金(No:81370983) 科技部国家仪器开发重大专项子课题(No:2011YQ03012414) 湖南省卫生厅科研基金(No:132013-010) 中南大学中央高校基本科研业务费专项资金资助(No:2013zzts312)
关键词 脂肪细胞 核酸适体 硫代修饰 荧光信号 HE染色 adipocyte aptamer phosphorothioate modified fluorescence signal HE staining
  • 相关文献

参考文献18

  • 1MENCIN N, SMUC T, VRANICAR M, et al. Optimization of SELEX: Comparison of different methods for monitoring theprogress of in vitro selection of aptamers[J]. J Pharm Biomed Anal, 2014, 91: 151-159.
  • 2SEFAH K, SHANGGUAN D, XIONG X, et al. Development of DNA aptamers using cell- SELEX [J]. Nat Protoc, 2010, 5 (6): 1169-1185.
  • 3KEEFE AD, PAI S, ELLINGTON A. Aptamers as therapeutics[J]. Nat Rev Drug Discov, 2010, 9(7): 537-550.
  • 4SHANGGUAN D, LI Y, TANG Z, et al. Aptamers evolved from live cells as effective molecular probes for cancer study[J]. Proc Natl Acad Sci USA, 2006, 103(32): 11838-11843.
  • 5LIU J, LIU H, SEFAH K, et al. Selection of aptamers specific for adipose tissue[J]. PLoS One, 2012, 7(5): e37789.
  • 6ASHRAF M J, BAWEJA P. Obesity: the 'huge' problem in car- diovascular diseases[J]. Mo Med, 2013, 110(6): 499-504.
  • 7SAKURAI T, OGASAWARA J, KIZAKI T, et al. The effects of exercise training on obesity-induced dysregulated expression of adipokines in white adipose tissue[J]. Int J Endocrinol, 2013, 2013: 1-28.
  • 8LEAL VO, MAFRA D. Adipokines in obesity[J]. Clin Chim Acta, 2013, 419: 87-94.
  • 9NAWROCKI AR, SCHERER PE. Keynote review: the adipocyte as a drug discovery target[J]. Drug Discov Today, 2005, 10(18): 1219-1230.
  • 10NG EW, SHIMA DT, CALIAS P, et al. Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease[J]. Nat Rev Drug Discov, 2006, 5(2): 123-132.

同被引文献3

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部